S100B and infection: This interaction is an attractive potential therapeutic target because an inhibitor that blocks the ability of Nef to interact with host cell factors important for enhancement of HIV-1 replication and T cell activation would be expected to reduce viral replication and, similar to infections with Nef-deleted strains of HIV and SIV, postpone the onset of AIDS.